Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients von DIACON, A. H, DAWSON, R, HANEKOM, M, NARUNSKY, K, VENTER, A, HITTER, N, GEITER, L. J, WELLS, C. D, PACCALY, A. J, DONALD, P. R

Volltext

Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis von Dawson, R., Narunsky, K., Carman, D., Gupte, N., Whitelaw, A., Efron, A., Barnes, G. L., Hoffman, J., Chaisson, R. E., McIlleron, H., Dorman, S. E.

Volltext

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis von Dorman, Susan E, Nahid, Payam, Kurbatova, Ekaterina V, Phillips, Patrick P.J, Bryant, Kia, Dooley, Kelly E, Engle, Melissa, Goldberg, Stefan V, Phan, Ha T.T, Hakim, James, Johnson, John L, Lourens, Madeleine, Martinson, Neil A, Muzanyi, Grace, Narunsky, Kim, Nerette, Sandy, Nguyen, Nhung V, Pham, Thuong H, Pierre, Samuel, Purfield, Anne E, Samaneka, Wadzanai, Savic, Radojka M, Sanne, Ian, Scott, Nigel A, Shenje, Justin, Sizemore, Erin, Vernon, Andrew, Waja, Ziyaad, Weiner, Marc, Swindells, Susan, Chaisson, Richard E

Volltext

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis von Gillespie, Stephen H, Crook, Angela M, McHugh, Timothy D, Mendel, Carl M, Meredith, Sarah K, Murray, Stephen R, Pappas, Frances, Phillips, Patrick P.J, Nunn, Andrew J

Volltext

Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824 von Diacon, Andreas H, Dawson, Rodney, du Bois, Jeannine, Narunsky, Kim, Venter, Amour, Donald, Peter R, van Niekerk, Christo, Erondu, Ngozi, Ginsberg, Ann M, Becker, Piet, Spigelman, Melvin K

Volltext

Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients von DIACON, Andreas H, DAWSON, Rodney, LAURENZI, Martino W, GINSBERG, Ann M, SPIGELMAN, Melvin K, HANEKOM, Madeleine, NARUNSKY, Kim, MARITZ, Stefan J, VENTER, Amour, DONALD, Peter R, VAN NIEKERK, Christo, WHITNEY, Karl, ROUSE, Doris J

Volltext

Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis von Aarnoutse, R E, Kibiki, G S, Reither, K, Semvua, H H, Haraka, F, Mtabho, C M, Mpagama, S G, van den Boogaard, J, Sumari-de Boer, I M, Magis-Escurra, C, Wattenberg, M, Logger, J G M, Te Brake, L H M, Hoelscher, M, Gillespie, S H, Colbers, A, Phillips, P P J, Plemper van Balen, G, Boeree, M J

Volltext

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis von Murthy, S E, Chatterjee, F, Crook, A, Dawson, R, Mendel, C, Murphy, M E, Murray, S R, Nunn, A J, Phillips, P P J, Singh, Kasha P, McHugh, T D, Gillespie, S H

Volltext

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study von Murphy, M E, Wills, G H, Murthy, S, Louw, C, Bateson, A L C, Hunt, R D, McHugh, T D, Nunn, A J, Meredith, S K, Mendel, C M, Spigelman, M, Crook, A M, Gillespie, S H

Volltext

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis von Murphy, Michael E, Phillips, Patrick P J, Mendel, Carl M, Bongard, Emily, Bateson, Anna L C, Hunt, Robert, Murthy, Saraswathi, Singh, Kasha P, Brown, Michael, Crook, Angela M, Nunn, Andrew J, Meredith, Sarah K, Lipman, Marc, McHugh, Timothy D, Gillespie, Stephen H

Volltext